Boston Scientific ’s Resonate Cardiac Implants with HeartLogic Predict Adverse Events, Now FDA Approved
Boston Scientific won approval from the FDA and is launching its Resonate line of implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillators (CRT-D). The implants include the firm’s HeartLogic diagnost...
Source: Medgadget - Category: Medical Devices Authors: Editors Tags: Cardiology Medicine Source Type: blogs
More News: Cardiac Resynchronization Therapy | Cardiology | Clinical Trials | Heart | Heart Failure | Medical Devices | PET Scan | Study | Warnings